CannaHorse, Inc USA Launches "EQUILIBRIUM ORAL" Cannabinoid Equine Health Product with Executive Leadership and Investment Update

Toronto, Ontario--(Newsfile Corp. - April 26, 2021) - CannaHorse, Inc. (USA) is proud to announce its first equine cannabinoid therapeutic product is now commercially available. EQUILIBRIUM ORAL is an ingested cannabinoid formulation designed to reduce anxiety in horses, formulated alongside Strainprint Technologies Ltd, the leading data and analytics company for the academic and commercial cannabis industry. The product line is derived from American hemp grown for medical purposes that is...

2021-04-26 8:00 AM EDT